Antibodies /
Saved in:
| Imprint: | New York : Kluwer Academic/Plenum Publishers, c2004. |
|---|---|
| Description: | 2 v. : ill. ; 24 cm. |
| Language: | English |
| Subject: | |
| Format: | E-Resource Print Book |
| URL for this record: | http://pi.lib.uchicago.edu/1001/cat/bib/5362003 |
Table of Contents:
- Volume 1:-.
- 1. Concepts in Development of Manufacturing Strategies for Monoclonal Antibodies
- 2. Antibody Fragments: Production, Purification and Formatting for Therapeutic Applications
- 3. Large Scale Production of Therapeutic Antibodies: Considerations for Optimizing Product Capture and Purification
- 4. Scale-Up of Antibody Purification. From Laboratory Scale to Production
- 5. Purification of Antibody by Chromatographic Methods
- 6. Quality Control of Antibodies for Human Use
- 7. Expression of Human Anti Rh(D) Monoclonal Antibodies into Different Cell lines: Influence on their Functional Properties
- 8. Monoclonal Antibody Production: Minimising Virus Safety Issues
- 9. Contract Manufacturing of Biopharmaceutical Grade Antibodies
- 10. The Pharmacokinetics and Pharmacodynamics of Monoclonal Antibodies
- 11. Regulatory and Legal Requirements for the Manufacture of Antibodies
- Index
- Volume 2:-.
- 1. Transgenic technology for monoclonal antibody production
- 2. Generation, engineering and production of human antibodies using HuCAL
- 3. Achieving appropriate glycosylation during the scaleup of antibody production
- 4. Approaches to devise antibody purification processes by chromatography
- 5. Novel HIV neutralizing antibodies selected from phage display libraries
- 6. Monoclonal and bispecific antibodies in combination with radiotherapy for cancer treatment
- 7. Antibodies, a potent tool to target genes into designated cells and tissues
- 8. Intrabodies: development and application in functional genomics and therapy
- 9. Expression of recombinant antibodies by tumour cells: on road to anti-tumour therapy
- 10. Antitumor antibodies: from research to clinic
- 11. Macrophages for immunotherapy
- 12. Future prospects in antibody engineering and therapy
- Index."
